跳至主要内容
临床试验/NCT06720272
NCT06720272尚未招募不适用

Effectiveness of an Integrated Program for the Prevention of Rheumatic Heart Disease in Endemic Regions: a Stepped Wedge Cluster Randomized Trial

Thomas Pilgrim2 个研究点 分布在 2 个国家目标入组 6,000 人开始时间: 2024年12月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
6,000
试验地点
2
主要终点
Rheumatic heart disease

研究概览

简要总结

The overall objective of the PREVENT trial is to evaluate the effectiveness of an integrated, school-based program for the prevention of rheumatic heart disease (RHD) in regions with an endemic pattern of RHD.

We conduct a stepped wedge cluster randomized trial in randomly selected schools in Nepal and Zambia.

The intervention will be delivered at the level of the school and consists in the introduction of a dedicated school-nurse program providing health care through education about RHD, assessment, intervention, and follow-up of GABHS pharyngitis, and facilitation of secondary antibiotic prophylaxis for children with RHD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
5 Years 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children aged 5-16 years

排除标准

  • Children / primary caregivers not providing informed consent to participate
  • Children not attending one of the selected schools

结局指标

主要结局

Rheumatic heart disease

时间窗: The endpoint will be assessed after a minimum of 1 and a maximum of 3 years after introduction of the school nurse program.

The primary outcome of the study will be the reduction in prevalence of rheumatic heart disease according to WHF criteria 2023 as assessed by systematic echocardiographic screening.

次要结局

未报告次要终点

研究者

发起方
Thomas Pilgrim
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Thomas Pilgrim

MD, MSc

Insel Gruppe AG, University Hospital Bern

研究点 (2)

Loading locations...

相似试验